Your Cart ( 1 Item )

• A Multicenter, Open-Label Study to Assess the Safety and Efficacy of Ciclopirox Topical Suspension 0.77% in the Treatment of Diaper Dermatitis Due to Candida Albicans
  January 2005 | Volume 4 | Issue 1 | Original Article | 29 | Copyright © January 2005
  Elizabeth Gallup MD JD MBA, The Ciclopirox TS Investigators, Todd Plott MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs